Colon-targeted celecoxib-loaded Eudragit®S100-coated poly-ϵ-caprolactone microparticles: Preparation, characterization andin vivoevaluation in rats

塞来昔布 药代动力学 生物利用度 体内 药理学 材料科学 药品 析因实验 己内酯 口服 化学 医学 聚合物 统计 生物技术 数学 复合材料 共聚物 生物
作者
Dalia Ghorab,Maha M. Amin,Omneya Mohammed Khowessah,Mina Ibrahim Tadros
出处
期刊:Drug Delivery [Taylor & Francis]
卷期号:18 (7): 523-535 被引量:38
标识
DOI:10.3109/10717544.2011.595841
摘要

Context: Celecoxib suffers from low and variable bioavailability following oral administration of solutions or capsules. Recent studies proved that chemoprevention of colorectal cancer is possible with celecoxib.Objective: This work aimed to tailor colon-targeted celecoxib-loaded microparticles using time-dependant and pH-dependant coats. Estimation of drug pharmacokinetics following oral administration to fasted rats was another goal.Methods: A 23 factorial design was adopted to develop poly-ϵ-caprolactone (PCL) celecoxib-loaded microparticles (F1–F8). To minimize drug-percentages released before colon, another coat of Eudragit® S100 was applied. In vitro characterization of microparticles involved topography, determination of particle size and entrapment efficiency (EE %). Time for 50% drug release (t50%) and drug-percentages released after 2 hours (Q2h) and 4 hours (Q4h) were statistically compared. Estimation of drug pharmacokinetics following oral administration of double-coat microparticles (F10) was studied in rats.Results: PCL-single-coat microparticles were spherical, discrete with a size range of 60.66 ± 4.21–277.20 ± 6.10 μm. Direct correlations were observed between surfactant concentration and EE%, Q2h and Q4h. The PCL M.wt. and drug: PCL ratio had positive influences on EE% and negative impacts on Q2h and Q4h. When compared to the best achieved PCL-single-coat microparticles (F2), the double-coat microparticles (F10) showed satisfactory drug protection; Q2h and Q4h were significantly (P < 0.01) decreased from 31.84 ± 1.98% and 54.72 ± 2.10% to 15.92 ± 1.78% and 26.93 ± 2.76%, respectively. When compared to celecoxib powder, F10 microparticles enhanced the bioavailability and extended the duration of drug-plasma concentration in rats.Conclusion: The developed double-coat microparticles could be considered as a promising celecoxib extended-release colon-targeting system.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Baiyu完成签到,获得积分10
1秒前
Huansun完成签到,获得积分10
1秒前
nuannuan发布了新的文献求助10
3秒前
帅气男孩应助Coco采纳,获得10
4秒前
量子星尘发布了新的文献求助10
5秒前
加一完成签到,获得积分10
6秒前
熊蔓蔓完成签到,获得积分10
8秒前
dingyi601完成签到,获得积分10
8秒前
tt123完成签到,获得积分10
8秒前
9秒前
糟糕的学姐完成签到,获得积分10
10秒前
yookia应助vbbbj采纳,获得10
10秒前
今后应助124cndhaP采纳,获得30
11秒前
meng完成签到 ,获得积分10
12秒前
HHHZZZ完成签到,获得积分10
12秒前
香蕉沧海发布了新的文献求助10
13秒前
高挑的梦芝完成签到,获得积分10
14秒前
婷123发布了新的文献求助20
14秒前
15秒前
我不爱池鱼应助Torment采纳,获得10
15秒前
小阮完成签到,获得积分10
15秒前
15秒前
迷人问兰发布了新的文献求助30
16秒前
vovoking完成签到 ,获得积分10
16秒前
17秒前
Jasper应助nuannuan采纳,获得10
17秒前
hzwyyds应助栗子采纳,获得10
19秒前
李希发布了新的文献求助50
19秒前
英俊的铭应助元宝采纳,获得10
20秒前
ZJHYNL应助111采纳,获得20
20秒前
早睡早起发布了新的文献求助10
21秒前
鳗鱼焦完成签到 ,获得积分10
21秒前
新威宝贝发布了新的文献求助10
22秒前
Jocd完成签到,获得积分10
27秒前
小二郎应助SAOKA采纳,获得10
29秒前
农夫果园完成签到,获得积分10
31秒前
33秒前
加二完成签到,获得积分10
34秒前
35秒前
辞忧完成签到,获得积分10
35秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
A new approach to the extrapolation of accelerated life test data 500
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3954469
求助须知:如何正确求助?哪些是违规求助? 3500461
关于积分的说明 11099572
捐赠科研通 3230989
什么是DOI,文献DOI怎么找? 1786217
邀请新用户注册赠送积分活动 869884
科研通“疑难数据库(出版商)”最低求助积分说明 801713